BTSG · XBRL financial data
BrightSpring Health Services financial statements, every quarter
The same tables from 11 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (BTSG's year ends in late December)
| In millions of dollars | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,577 | 2,730 | 2,907 | — | — | — | — | — | — | — | — |
| Revenue from contracts with customers | 2,577 | 2,730 | 2,907 | 3,053* | 2,878 | 3,148 | 3,334 | 3,551* | 3,614 | 3,873 | 4,213 |
| Cost of goods and services sold | 2,207 | 2,341 | 2,499 | — | — | — | — | — | — | — | — |
| Gross profit | 369 | 389 | 408 | — | 338 | 375 | 392 | — | 482 | 493 | 519 |
| Selling, general and administrative | 361 | 327 | 351 | 343* | 288 | 326 | 304 | 304* | 361 | 362 | 358 |
| Operating income (loss) | 8 | 62 | 57 | 79* | 51 | 49 | 88 | 108* | 121 | 130 | 160 |
| Interest expense | 65 | 52 | 56 | 55* | 42 | 39 | 38 | 39* | 39 | 37 | 31 |
| Income tax expense (benefit) | (23) | (9) | 10 | 9* | (0) | 1 | 12 | 20* | 9 | 7 | 29 |
| Net income (loss) | (46) | 20 | (8) | 16* | 30 | 28 | 56 | 77* | 149 | 84 | 100 |
| Earnings per share, basic USD per share | (0.26) | 0.10 | (0.04) | 0.08* | 0.15 | 0.14 | 0.27 | 0.38* | 0.73 | 0.41 | 0.48 |
| Earnings per share, diluted USD per share | (0.26) | 0.10 | (0.04) | 0.08* | 0.14 | 0.13 | 0.26 | 0.34* | 0.67 | 0.38 | 0.45 |
| Weighted average shares, basic millions of shares | 176 | 198 | 198 | 200* | 201 | 202 | 203 | 204* | 205 | 206 | 207 |
| Weighted average shares, diluted millions of shares | 176 | 209 | 198 | 189* | 215 | 216 | 218 | 230* | 221 | 220 | 220 |
Balance sheet
CSVFiscal quarters (BTSG's year ends in late December)
Cash flows
CSVFiscal quarters (BTSG's year ends in late December)
| In millions of dollars | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (46) | 20 | (8) | 16* | 30 | 28 | 56 | 77* | 149 | 84 | 100 |
| Stock-based compensation | 25 | 15* | 15* | 14* | 16 | 23* | 17* | 14* | 4 | 19* | 18* |
| Net cash from operating activities | (79) | (15)* | 27* | 91* | 102 | 49* | 108* | 232* | 123 | 44* | 204* |
| Purchases of property and equipment | 22 | 24* | 20* | 15* | 18 | 24* | 16* | 38* | 22 | 29* | 22* |
| Net cash from investing activities | (31) | (58)* | (36)* | (16)* | (24) | (23)* | (24)* | (234)* | 747 | (28)* | (23)* |
| Share repurchases | 0 | 0* | 0* | 0* | — | — | — | year only | 60 | 60* | 0* |
| Proceeds from long-term debt | 2,566 | 0* | 0* | 0* | — | — | — | — | — | — | — |
| Repayments of long-term debt | 793 | 2,578* | 14* | 12* | 12 | 12* | 14* | 12* | 12 | 308* | 12* |
| Net cash from financing activities | 155 | 40* | 20* | (50)* | (86) | (8)* | (13)* | (50)* | (70) | (354)* | (14)* |
| Net change in cash | 45 | (33)* | 11* | 25* | (9) | 18* | 71* | (53)* | 800 | (338)* | 167* |
Compare with peers
SIC 8082 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8082 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| BrightSpring Health Services | 718 | 4,213 | 204* | 199.0M | 10-QSep 30, 2026 |
| Addus HomeCare | 100 | 377 | 40* | 18.7M | 10-QJun 30, 2026 |
| Option Care Health | 299 | 1,494 | 115* | 149.8M | 10-QSep 30, 2026 |
| AdaptHealth | not reported | 746 | 157* | 136.5M | 10-QSep 30, 2026 |
| Chemed | 48 | 691 | 57* | 13.0M | 10-QSep 30, 2026 |
| Enhabit | 50 | 265 | 35 | 51.2M | 10-QMar 31, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
